Experimental pharmacological research regarding some new quinazolin-4-ones derivatives

• Published in: Journal of Mind and Medical Sciences Vol. 6; no. 1; pp. 121 - 129
• Main Authors: Chiriță, Cornel, Ștefănescu, Emil, Zbârcea, Cristina, Negreș, Simona, Bratu, Mihaela, Nuță, Diana, Limban, Carmen, Chiriță, Ileana, Marineci, Cristina
• Format: Journal Article
• Language: English
• Published: Ion Motofei, Carol Davila University 01.05.2019
• Subjects: analgesic; antidepressant; anxiolytic; pharmacological research; quinazolin-4-one derivatives
• ISSN: 2392-7674; 2392-7674
• DOI: 10.22543/7674.61.P121129

A series of new compounds with quinazolin-4-one structure, synthesized by the Pharmaceutical Chemistry Department of the Faculty of Pharmacy of the University of Medicine and Pharmacy “Carol Davila” Bucharest, was studied. Five of them were selected, conventionally named S1, S2, S3, S4, S5, and investigated in terms of their potential influence on the central nervous system (CNS). For this purpose, the antidepressant effect was determined using the forced swimming test; the anxiolytic/ anxiogenic effect was determined using the suspended plus-shaped maze (Ugo Basile); the effect on the motor activity was determined using the Ugo Basile activity cage; and the potential analgesic effect was investigated using the hot plate test (Ugo Basile). Compounds S3 and S5 lowered the motor activity and showed an anxiolytic effect, while S1 and S2 proved to have antidepressant and analgesic effects. A good correlation between antidepressant and analgesic effects was observed, consistent with the fact that analgesic drugs, by increasing norepinephrine and serotonin levels in the pain inhibiting descendent pathways, can be used as co-analgesics in therapy.